A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co-loaded liposomal formulation

[Display omitted] Osteosarcoma is the most common cancer in bone. Drug resistance is a challenge of current treatments that needs to be improved with novel treatment strategies. In this research, a new dual drug delivery system was developed with Gemcitabine (GEM) and Clofazimine (CLF) co-loaded lip...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of pharmaceutics 2019-02, Vol.557, p.97-104
Hauptverfasser:	Caliskan, Yagmur, Dalgic, Ali Deniz, Gerekci, Selin, Gulec, Ezgi A., Tezcaner, Aysen, Ozen, Can, Keskin, Dilek
Format:	Artikel
Sprache:	eng
Schlagworte:	Clofazimine Co-loading Gemcitabine Liposome Multi-drug delivery Osteosarcoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!